Share
Market Research Report

LIQUID BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Biomarker TypeCTC (Circulating Tumor Cells) · ctNA (Circulating Tumor Nucliec Acids) · Exosomes
  • By Sample TypeBlood · Urine · Others
  • By Disease IndicationLung Cancer · Gastrointestinal Cancer · Prostate Cancer · Breast Cancer · Colorectal Cancer · Leukemia · Others · etc.
  • By End UserHospitals · Cancer Institutes · Academic Institutes · Diagnostic Centers
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In13 Apr 2026
  • Report CodeCMI1223
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Biomarker Type
      • Market Snippet, By Sample Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Liquid Biopsy Market, By Biomarker Type, 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • CTC (Circulating Tumor Cells)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • ctNA (Circulating Tumor Nucliec Acids)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • Exosomes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
  5. Global Liquid Biopsy Market, By Sample Type, 2021 – 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Blood
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • Urine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
  6. Global Liquid Biopsy Market, By Disease Indication 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Lung Cancer
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Gastrointestinal Cancer
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Prostate Cancer
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Breast Cancer
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Colorectal Cancer
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Leukemia
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Others
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
  7. Global Liquid Biopsy Market, By End User 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Cancer Institutes
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Academic Institutes
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
    • Diagnostic Centers
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million)
  8. Global Liquid Biopsy Market, By Region, 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
    • North America
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape

    • Company Profiles
      • Biocept, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Qiagen N.V
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Trovagene, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Janssen Global Services, LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • MDxHealth SA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Natera, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Silicon Biosystems
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pathway Genomics Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sysmex Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 20 figures on “Liquid Biopsy – Global forecast to 2033.